1. Adeboyeku, D., McKenzie, D., Hodson, M.E., 1998. A review of one year date of first-dose challenges of inhaled antibiotics in adult cystic fibrosis (CF) patients. 12th Annual North American Cystic fibrosis conference, Montreal, Quebec, Canada, 15–18 October. Ped Pulm 26, Suppl. 17, A405.
2. Pulmonary function response to EDTA, an additive in nebulized bronchodilators;Asmus;J. Allerg. Clin. Immunol.,2001
3. Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis;Barker;Am. J. Respir. Crit. Care Med.,2000
4. The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulisers;Clark;Int. J. Pharm.,1995
5. Crockett, A.J., Cranston, J.M., Latimer, K.M., Alpers, J.H., 2004. Mucolytics for bronchiectasis. The Cochrane Library.